265 related articles for article (PubMed ID: 20965447)
1. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
[TBL] [Abstract][Full Text] [Related]
2. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
[TBL] [Abstract][Full Text] [Related]
3. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
4. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
[TBL] [Abstract][Full Text] [Related]
6. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.
Valiengo L; Benseñor IM; Goulart AC; de Oliveira JF; Zanao TA; Boggio PS; Lotufo PA; Fregni F; Brunoni AR
Depress Anxiety; 2013 Jul; 30(7):646-53. PubMed ID: 23625554
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
8. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
[TBL] [Abstract][Full Text] [Related]
9. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.
Richieri R; Guedj E; Michel P; Loundou A; Auquier P; Lançon C; Boyer L
J Affect Disord; 2013 Oct; 151(1):129-35. PubMed ID: 23790811
[TBL] [Abstract][Full Text] [Related]
10. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
Lisanby SH; Husain MM; Rosenquist PB; Maixner D; Gutierrez R; Krystal A; Gilmer W; Marangell LB; Aaronson S; Daskalakis ZJ; Canterbury R; Richelson E; Sackeim HA; George MS
Neuropsychopharmacology; 2009 Jan; 34(2):522-34. PubMed ID: 18704101
[TBL] [Abstract][Full Text] [Related]
11. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
[TBL] [Abstract][Full Text] [Related]
12. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
[TBL] [Abstract][Full Text] [Related]
13. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis.
Rakesh G; Cordero P; Khanal R; Himelhoch SS; Rush CR
J Affect Disord; 2024 Aug; 358():432-439. PubMed ID: 38740269
[TBL] [Abstract][Full Text] [Related]
14. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
[TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
[TBL] [Abstract][Full Text] [Related]
16. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
Demitrack MA; Thase ME
Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
[TBL] [Abstract][Full Text] [Related]
19. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
[TBL] [Abstract][Full Text] [Related]
20. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
